Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) Shares Outstanding (Diluted Average) (2021 - 2025)

Rxo (RXO) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $168.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 26.27% year-over-year to $168.5 million, compared with a TTM value of $168.5 million through Dec 2025, up 26.27%, and an annual FY2025 reading of $168.5 million, up 26.27% over the prior year.
  • Shares Outstanding (Diluted Average) was $168.5 million for Q4 2025 at Rxo, roughly flat from $168.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $168.6 million in Q3 2025 and bottomed at $115.2 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $130.4 million, with a median of $119.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) decreased 1.8% in 2024, then soared 43.34% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $115.2 million in 2021, then increased by 0.55% to $115.8 million in 2022, then grew by 3.17% to $119.5 million in 2023, then increased by 11.68% to $133.4 million in 2024, then grew by 26.27% to $168.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for RXO at $168.5 million in Q4 2025, $168.6 million in Q3 2025, and $168.3 million in Q2 2025.